English

PDS BIOTECHNOLOGY CORPORATION

EDGAR

PDSB Current report (8-K) · filed 2026-10-21

149 filing records in this dataset, filed from 2015-08-14 to 2026-10-21. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 5.6 million U002 2026-06-30 Source
Exact value

5600000 U002
Long-term debt including current maturities: 15 million U002 2016-09-30 Source
Exact value

15000000 U002
Shares outstanding: 55.9 million U001 2026-06-30 Source
Exact value

55921806 U001

Reported share-count change

19.92% · 9.29 million U001

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

46633362 U001 · 2025-06-30· Source
55921806 U001 · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-21.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 7 of 11 periods available· newest 2025-12-31
Total assets: Multiple units; comparison withheld· newest 2025-12-31
Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
Current assets: Multiple units; comparison withheld· newest 2025-12-31
Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2015-12-31
Shares outstanding: Multiple units; comparison withheld· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+U001 3.11 million

Prior period

−U001 37.61 million

2024-01-01 – 2024-12-31
Current period

−U001 34.5 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-34495505 − -37610384 = 3114879 U001

-37610384 U001 · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-34495505 U001 · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PDS BIOTECHNOLOGY CORPORATION · 2025-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Year-over-year change in Net income: 3114879 U001 Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -34495505 U001 (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#2458770 Filing: 000114036126012030 Input fundies:NetIncome: -37610384 U001 (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#2460358 Filing: 000114036126012030
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+U001 7.28 million

Prior period

−U001 35.03 million

2024-01-01 – 2024-12-31
Current period

−U001 27.75 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-27752012 − -35030223 = 7278211 U001

-35030223 U001 · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-27752012 U001 · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PDS BIOTECHNOLOGY CORPORATION · 2025-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Year-over-year change in Operating cash flow: 7278211 U001 Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -27752012 U001 (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#1809310 Filing: 000114036126012030 Input fundies:OperatingCashFlow: -35030223 U001 (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#1810268 Filing: 000114036126012030
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

U001 29,000

2024-01-01 – 2024-12-31
Current period

U001 0

2025-01-01 – 2025-12-31

Exact inputs and evidence

0 − 29000 = -29000 U001

29000 U001 · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
0 U001 · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PDS BIOTECHNOLOGY CORPORATION · 2025-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Year-over-year change in Capital expenditure: -29000 U001 Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 U001 (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#1814110 Filing: 000114036126012030 Input fundies:CapitalExpenditure: 29000 U001 (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#1815064 Filing: 000114036126012030
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(U001)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−U001 38.82 million Exact value Exact value: -38820998 U001 2016-01-01 – 2016-12-31: -38820998 U001 Inspect Net Income Open source Share or cite Citation for Net Income · PDS BIOTECHNOLOGY CORPORATION · 2016-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Net Income: -38820998 U001 Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=U001&dimensions= Input fundies:NetIncome: -38820998 U001 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036118045551/edge-20181220.xml#473226 Filing: 000114036118045551 The citation records this snapshot. The page link may show a newer release later.	−U001 32.19 million Exact value Exact value: -32188668 U001 2016-01-01 – 2016-12-31: -32188668 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PDS BIOTECHNOLOGY CORPORATION · 2016-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Operating Cash Flow: -32188668 U001 Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -32188668 U001 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036118045551/edge-20181220.xml#472892 Filing: 000114036118045551 The citation records this snapshot. The page link may show a newer release later.	U001 686,705 Exact value Exact value: 686705 U001 2016-01-01 – 2016-12-31: 686705 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PDS BIOTECHNOLOGY CORPORATION · 2016-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Capital Expenditure: 686705 U001 Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 686705 U001 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036118045551/edge-20181220.xml#492845 Filing: 000114036118045551 The citation records this snapshot. The page link may show a newer release later.	−U001 32.88 million Calculation and evidence -32188668 − 686705 U001 Exact free cash flow: -32875373 U001 2016-01-01 – 2016-12-31: -32188668 U001 · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 686705 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PDS BIOTECHNOLOGY CORPORATION · 2016-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Free cash flow: -32875373 U001 Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -32188668 U001 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036118045551/edge-20181220.xml#472892 Filing: 000114036118045551 Input fundies:CapitalExpenditure: 686705 U001 (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036118045551/edge-20181220.xml#492845 Filing: 000114036118045551 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−U001 50.86 million Exact value Exact value: -50859803 U001 2017-01-01 – 2017-12-31: -50859803 U001 Inspect Net Income Open source Share or cite Citation for Net Income · PDS BIOTECHNOLOGY CORPORATION · 2017-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Net Income: -50859803 U001 Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=U001&dimensions= Input fundies:NetIncome: -50859803 U001 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036119003636/edge-20181231.xml#439782 Filing: 000114036119003636 The citation records this snapshot. The page link may show a newer release later.	−U001 40.7 million Exact value Exact value: -40696831 U001 2017-01-01 – 2017-12-31: -40696831 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PDS BIOTECHNOLOGY CORPORATION · 2017-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Operating Cash Flow: -40696831 U001 Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -40696831 U001 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036119003636/edge-20181231.xml#439554 Filing: 000114036119003636 The citation records this snapshot. The page link may show a newer release later.	U001 188,721 Exact value Exact value: 188721 U001 2017-01-01 – 2017-12-31: 188721 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PDS BIOTECHNOLOGY CORPORATION · 2017-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Capital Expenditure: 188721 U001 Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 188721 U001 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036119003636/edge-20181231.xml#453394 Filing: 000114036119003636 The citation records this snapshot. The page link may show a newer release later.	−U001 40.89 million Calculation and evidence -40696831 − 188721 U001 Exact free cash flow: -40885552 U001 2017-01-01 – 2017-12-31: -40696831 U001 · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 188721 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PDS BIOTECHNOLOGY CORPORATION · 2017-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Free cash flow: -40885552 U001 Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -40696831 U001 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036119003636/edge-20181231.xml#439554 Filing: 000114036119003636 Input fundies:CapitalExpenditure: 188721 U001 (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036119003636/edge-20181231.xml#453394 Filing: 000114036119003636 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−U001 3.84 million Exact value Exact value: -3836481 U001 2018-01-01 – 2018-12-31: -3836481 U001 Inspect Net Income Open source Share or cite Citation for Net Income · PDS BIOTECHNOLOGY CORPORATION · 2018-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Net Income: -3836481 U001 Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=U001&dimensions= Input fundies:NetIncome: -3836481 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036120007252/pdsb-20191231.xml#698114 Filing: 000114036120007252 The citation records this snapshot. The page link may show a newer release later.	−U001 1.57 million Exact value Exact value: -1569577 U001 2018-01-01 – 2018-12-31: -1569577 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PDS BIOTECHNOLOGY CORPORATION · 2018-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Operating Cash Flow: -1569577 U001 Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -1569577 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036120007252/pdsb-20191231.xml#695021 Filing: 000114036120007252 The citation records this snapshot. The page link may show a newer release later.	U001 0 Exact value Exact value: 0 U001 2018-01-01 – 2018-12-31: 0 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PDS BIOTECHNOLOGY CORPORATION · 2018-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Capital Expenditure: 0 U001 Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 0 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036119003636/edge-20181231.xml#453164 Filing: 000114036119003636 The citation records this snapshot. The page link may show a newer release later.	−U001 1.57 million Calculation and evidence -1569577 − 0 U001 Exact free cash flow: -1569577 U001 2018-01-01 – 2018-12-31: -1569577 U001 · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 0 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PDS BIOTECHNOLOGY CORPORATION · 2018-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Free cash flow: -1569577 U001 Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1569577 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036120007252/pdsb-20191231.xml#695021 Filing: 000114036120007252 Input fundies:CapitalExpenditure: 0 U001 (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036119003636/edge-20181231.xml#453164 Filing: 000114036119003636 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−U001 7 million Exact value Exact value: -6998606 U001 2019-01-01 – 2019-12-31: -6998606 U001 Inspect Net Income Open source Share or cite Citation for Net Income · PDS BIOTECHNOLOGY CORPORATION · 2019-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Net Income: -6998606 U001 Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=U001&dimensions= Input fundies:NetIncome: -6998606 U001 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036121009142/pdsb-20201231.xml#451967 Filing: 000114036121009142 The citation records this snapshot. The page link may show a newer release later.	−U001 18.07 million Exact value Exact value: -18073469 U001 2019-01-01 – 2019-12-31: -18073469 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PDS BIOTECHNOLOGY CORPORATION · 2019-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Operating Cash Flow: -18073469 U001 Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -18073469 U001 (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036121009142/pdsb-20201231.xml#451547 Filing: 000114036121009142 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−U001 14.85 million Exact value Exact value: -14847380 U001 2020-01-01 – 2020-12-31: -14847380 U001 Inspect Net Income Open source Share or cite Citation for Net Income · PDS BIOTECHNOLOGY CORPORATION · 2020-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Net Income: -14847380 U001 Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=U001&dimensions= Input fundies:NetIncome: -14847380 U001 (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036122012244/brhc10035378_10k.htm#1058623 Filing: 000114036122012244 The citation records this snapshot. The page link may show a newer release later.	−U001 13.15 million Exact value Exact value: -13149135 U001 2020-01-01 – 2020-12-31: -13149135 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PDS BIOTECHNOLOGY CORPORATION · 2020-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Operating Cash Flow: -13149135 U001 Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -13149135 U001 (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036122012244/brhc10035378_10k.htm#1081057 Filing: 000114036122012244 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−U001 16.92 million Exact value Exact value: -16918477 U001 2021-01-01 – 2021-12-31: -16918477 U001 Inspect Net Income Open source Share or cite Citation for Net Income · PDS BIOTECHNOLOGY CORPORATION · 2021-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Net Income: -16918477 U001 Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=U001&dimensions= Input fundies:NetIncome: -16918477 U001 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036123014279/brhc10050281_10k.htm#1428373 Filing: 000114036123014279 The citation records this snapshot. The page link may show a newer release later.	−U001 12.49 million Exact value Exact value: -12486066 U001 2021-01-01 – 2021-12-31: -12486066 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PDS BIOTECHNOLOGY CORPORATION · 2021-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Operating Cash Flow: -12486066 U001 Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -12486066 U001 (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036123014279/brhc10050281_10k.htm#1458735 Filing: 000114036123014279 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−U001 40.85 million Exact value Exact value: -40854855 U001 2022-01-01 – 2022-12-31: -40854855 U001 Inspect Net Income Open source Share or cite Citation for Net Income · PDS BIOTECHNOLOGY CORPORATION · 2022-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Net Income: -40854855 U001 Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=U001&dimensions= Input fundies:NetIncome: -40854855 U001 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036124016265/ef20015299_10k.htm#1550573 Filing: 000114036124016265 The citation records this snapshot. The page link may show a newer release later.	−U001 25.71 million Exact value Exact value: -25709706 U001 2022-01-01 – 2022-12-31: -25709706 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PDS BIOTECHNOLOGY CORPORATION · 2022-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Operating Cash Flow: -25709706 U001 Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -25709706 U001 (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036124016265/ef20015299_10k.htm#1580853 Filing: 000114036124016265 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2023-01-01 – 2023-12-31	−U001 42.94 million Exact value Exact value: -42942198 U001 2023-01-01 – 2023-12-31: -42942198 U001 Inspect Net Income Open source Share or cite Citation for Net Income · PDS BIOTECHNOLOGY CORPORATION · 2023-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Net Income: -42942198 U001 Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=U001&dimensions= Input fundies:NetIncome: -42942198 U001 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036125010717/ef20039023_10k.htm#2166353 Filing: 000114036125010717 The citation records this snapshot. The page link may show a newer release later.	−U001 33.64 million Exact value Exact value: -33636136 U001 2023-01-01 – 2023-12-31: -33636136 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PDS BIOTECHNOLOGY CORPORATION · 2023-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Operating Cash Flow: -33636136 U001 Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -33636136 U001 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036125010717/ef20039023_10k.htm#1649690 Filing: 000114036125010717 The citation records this snapshot. The page link may show a newer release later.	U001 0 Exact value Exact value: 0 U001 2023-01-01 – 2023-12-31: 0 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PDS BIOTECHNOLOGY CORPORATION · 2023-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Capital Expenditure: 0 U001 Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 0 U001 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036125010717/ef20039023_10k.htm#1654510 Filing: 000114036125010717 The citation records this snapshot. The page link may show a newer release later.	−U001 33.64 million Calculation and evidence -33636136 − 0 U001 Exact free cash flow: -33636136 U001 2023-01-01 – 2023-12-31: -33636136 U001 · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 0 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PDS BIOTECHNOLOGY CORPORATION · 2023-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Free cash flow: -33636136 U001 Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -33636136 U001 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036125010717/ef20039023_10k.htm#1649690 Filing: 000114036125010717 Input fundies:CapitalExpenditure: 0 U001 (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036125010717/ef20039023_10k.htm#1654510 Filing: 000114036125010717 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−U001 37.61 million Exact value Exact value: -37610384 U001 2024-01-01 – 2024-12-31: -37610384 U001 Inspect Net Income Open source Share or cite Citation for Net Income · PDS BIOTECHNOLOGY CORPORATION · 2024-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Net Income: -37610384 U001 Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=U001&dimensions= Input fundies:NetIncome: -37610384 U001 (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#2460358 Filing: 000114036126012030 The citation records this snapshot. The page link may show a newer release later.	−U001 35.03 million Exact value Exact value: -35030223 U001 2024-01-01 – 2024-12-31: -35030223 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PDS BIOTECHNOLOGY CORPORATION · 2024-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Operating Cash Flow: -35030223 U001 Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -35030223 U001 (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#1810268 Filing: 000114036126012030 The citation records this snapshot. The page link may show a newer release later.	U001 29,000 Exact value Exact value: 29000 U001 2024-01-01 – 2024-12-31: 29000 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PDS BIOTECHNOLOGY CORPORATION · 2024-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Capital Expenditure: 29000 U001 Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 29000 U001 (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#1815064 Filing: 000114036126012030 The citation records this snapshot. The page link may show a newer release later.	−U001 35.06 million Calculation and evidence -35030223 − 29000 U001 Exact free cash flow: -35059223 U001 2024-01-01 – 2024-12-31: -35030223 U001 · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 29000 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PDS BIOTECHNOLOGY CORPORATION · 2024-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Free cash flow: -35059223 U001 Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -35030223 U001 (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#1810268 Filing: 000114036126012030 Input fundies:CapitalExpenditure: 29000 U001 (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#1815064 Filing: 000114036126012030 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−U001 34.5 million Exact value Exact value: -34495505 U001 2025-01-01 – 2025-12-31: -34495505 U001 Inspect Net Income Open source Share or cite Citation for Net Income · PDS BIOTECHNOLOGY CORPORATION · 2025-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Net Income: -34495505 U001 Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=U001&dimensions= Input fundies:NetIncome: -34495505 U001 (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#2458770 Filing: 000114036126012030 The citation records this snapshot. The page link may show a newer release later.	−U001 27.75 million Exact value Exact value: -27752012 U001 2025-01-01 – 2025-12-31: -27752012 U001 Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PDS BIOTECHNOLOGY CORPORATION · 2025-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Operating Cash Flow: -27752012 U001 Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=U001&dimensions= Input fundies:OperatingCashFlow: -27752012 U001 (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#1809310 Filing: 000114036126012030 The citation records this snapshot. The page link may show a newer release later.	U001 0 Exact value Exact value: 0 U001 2025-01-01 – 2025-12-31: 0 U001 Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PDS BIOTECHNOLOGY CORPORATION · 2025-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Capital Expenditure: 0 U001 Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=U001&dimensions= Input fundies:CapitalExpenditure: 0 U001 (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#1814110 Filing: 000114036126012030 The citation records this snapshot. The page link may show a newer release later.	−U001 27.75 million Calculation and evidence -27752012 − 0 U001 Exact free cash flow: -27752012 U001 2025-01-01 – 2025-12-31: -27752012 U001 · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 0 U001 · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PDS BIOTECHNOLOGY CORPORATION · 2025-12-31 PDS BIOTECHNOLOGY CORPORATION (edgar:1472091) Free cash flow: -27752012 U001 Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:53:37Z Snapshot: 0163597198cb25f11a14718c7d3fbb5c9ec0a742fb225457a70f777d7f9b86ac Dimensions: Consolidated View: https://fundies.io/companies/edgar/1472091?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27752012 U001 (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#1809310 Filing: 000114036126012030 Input fundies:CapitalExpenditure: 0 U001 (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1472091/000114036126012030/ef20060644_10k.htm#1814110 Filing: 000114036126012030 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

149 filings · 2,759 latest values · 2,759 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001472091, 1472091, PDSB, edgar:1472091

Also known as Edge Therapeutics, Inc., PDS BIOTECHNOLOGY CORPORATION, PDS Biotechnology Corp, PDS Biotechnology Corporation

PDS BIOTECHNOLOGY CORPORATION

Reported share-count change

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation